# Intranasal Delivery of Testosterone and Its Effect on Doping Markers

> **NCT02611154** · PHASE4 · COMPLETED · sponsor: **University of Utah** · enrollment: 5 (actual)

## Conditions studied

- Abuse of Anabolic Steroids

## Interventions

- **DRUG:** Testosterone

## Key facts

- **NCT ID:** NCT02611154
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-18
- **Primary completion:** 2016-01-19
- **Final completion:** 2016-01-19
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-02-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02611154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02611154, "Intranasal Delivery of Testosterone and Its Effect on Doping Markers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02611154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*